Skip to content

Clinical trials

Observational Waldenstrom Macroglobulinemia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Phase: Observational Country / region: United States Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20032
20052
20061
20071
20083
20094
20101
20142
20212
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting6
Active, not recruiting3
Not yet recruiting1
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Dana-Farber Cancer Institute2
Mayo Clinic2
SWOG Cancer Research Network2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2
UNC Lineberger Comprehensive Cancer Center2
Wake Forest University Health Sciences2
BeiGene1
Case Comprehensive Cancer Center1
City of Hope Medical Center1
Fred Hutchinson Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia24
Leukemia, Lymphocytic, Chronic, B-Cell18
Lymphoma, B-Cell, Marginal Zone15
Lymphoma14
Lymphoma, Mantle-Cell14
Lymphoma, Non-Hodgkin14
Precursor Cell Lymphoblastic Leukemia-Lymphoma14
Burkitt Lymphoma12
Lymphoma, Follicular12
Lymphoma, Large B-Cell, Diffuse12

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.